A GLP-1 weight loss drug lawsuit gives patients and families a way to hold manufacturers accountable when the risks of these medications outweigh the benefits
Some people may feel full quickly, feel bloated after eating, or notice more burping than usual
One interesting theory Ive heard is that in people with a long history of alcohol-use disorder of heavy drinking that the blood-brain barrier becomes leakier, that its easier for different things to cross into the brain, and that, again, this may be one reason that GLP-1s perhaps are more effective in reducing substance use for people with alcohol-use disorder than other drugs
Yeah, but someday maybe when I have a couple extra dollars
The approval comes after a positive recommendation from the European Medicines Agency in May, giving the Danish drugmaker a head start in the race to dominate the emerging weight-loss pill market alongside Eli Lilly's Foundayo, which has yet to clear the EU regulatory pathway
Alfthan G, Aro A, Arvilommi H, Huttunen JK
